379 related articles for article (PubMed ID: 28969890)
1. Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Fatheree NY; Liu Y; Taylor CM; Hoang TK; Cai C; Rahbar MH; Hessabi M; Ferris M; McMurtry V; Wong C; Vu T; Dancsak T; Wang T; Gleason W; Bandla V; Navarro F; Tran DQ; Rhoads JM
J Pediatr; 2017 Dec; 191():170-178.e2. PubMed ID: 28969890
[TBL] [Abstract][Full Text] [Related]
2. Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.
Savino F; Garro M; Montanari P; Galliano I; Bergallo M
J Pediatr; 2018 Jan; 192():171-177.e1. PubMed ID: 28969887
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.
Chau K; Lau E; Greenberg S; Jacobson S; Yazdani-Brojeni P; Verma N; Koren G
J Pediatr; 2015 Jan; 166(1):74-8. PubMed ID: 25444531
[TBL] [Abstract][Full Text] [Related]
4. Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial.
Tyrsin OY; Tyrsin DY; Nemenov DG; Ruzov AS; Odintsova VE; Koshechkin SI; D Amico L
Eur J Pediatr; 2024 May; 183(5):2311-2324. PubMed ID: 38427038
[TBL] [Abstract][Full Text] [Related]
5. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.
Sung V; Hiscock H; Tang ML; Mensah FK; Nation ML; Satzke C; Heine RG; Stock A; Barr RG; Wake M
BMJ; 2014 Apr; 348():g2107. PubMed ID: 24690625
[TBL] [Abstract][Full Text] [Related]
6.
Sung V; D'Amico F; Cabana MD; Chau K; Koren G; Savino F; Szajewska H; Deshpande G; Dupont C; Indrio F; Mentula S; Partty A; Tancredi D
Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29279326
[TBL] [Abstract][Full Text] [Related]
7. Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.
Nation ML; Dunne EM; Joseph SJ; Mensah FK; Sung V; Satzke C; Tang MLK
Sci Rep; 2017 Nov; 7(1):15047. PubMed ID: 29118383
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of the prenatal administration of Lactobacillus reuteri LR92 DSM 26866 on the prevention of infantile colic: a randomized control trial.
Pourmirzaiee MA; Famouri F; Moazeni W; Hassanzadeh A; Hajihashemi M
Eur J Pediatr; 2020 Oct; 179(10):1619-1626. PubMed ID: 32372186
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial.
Savino F; Cordisco L; Tarasco V; Palumeri E; Calabrese R; Oggero R; Roos S; Matteuzzi D
Pediatrics; 2010 Sep; 126(3):e526-33. PubMed ID: 20713478
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with
Savino F; Galliano I; Garro M; Savino A; Daprà V; Montanari P; Bergallo M
Benef Microbes; 2018 Dec; 9(6):917-925. PubMed ID: 30406696
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.
Szajewska H; Gyrczuk E; Horvath A
J Pediatr; 2013 Feb; 162(2):257-62. PubMed ID: 22981952
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial.
Indrio F; Di Mauro A; Riezzo G; Civardi E; Intini C; Corvaglia L; Ballardini E; Bisceglia M; Cinquetti M; Brazzoduro E; Del Vecchio A; Tafuri S; Francavilla R
JAMA Pediatr; 2014 Mar; 168(3):228-33. PubMed ID: 24424513
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial.
Mi GL; Zhao L; Qiao DD; Kang WQ; Tang MQ; Xu JK
Antonie Van Leeuwenhoek; 2015 Jun; 107(6):1547-53. PubMed ID: 25876529
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials.
Xu M; Wang J; Wang N; Sun F; Wang L; Liu XH
PLoS One; 2015; 10(10):e0141445. PubMed ID: 26509502
[TBL] [Abstract][Full Text] [Related]
15. Probiotics to prevent infantile colic.
Ong TG; Gordon M; Banks SS; Thomas MR; Akobeng AK
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012473. PubMed ID: 30865287
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study.
Savino F; Pelle E; Palumeri E; Oggero R; Miniero R
Pediatrics; 2007 Jan; 119(1):e124-30. PubMed ID: 17200238
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial.
Pärtty A; Lehtonen L; Kalliomäki M; Salminen S; Isolauri E
Pediatr Res; 2015 Oct; 78(4):470-5. PubMed ID: 26151493
[TBL] [Abstract][Full Text] [Related]
18. Probiotics for infantile colic: a systematic review.
Anabrees J; Indrio F; Paes B; AlFaleh K
BMC Pediatr; 2013 Nov; 13():186. PubMed ID: 24238101
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolome of infants with colic treated with Lactobacillus reuteri DSM 17938: a pilot randomized trial.
Savino F; Fanos V; Noto A; Biggio D; Fattuoni C; Barberini L
Minerva Pediatr (Torino); 2024 Jun; 76(3):404-413. PubMed ID: 33438855
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a partially hydrolysed formula, with reduced lactose content and with Lactobacillus reuteri DSM 17938 in infant colic: A double blind, randomised clinical trial.
Turco R; Russo M; Bruzzese D; Staiano A
Clin Nutr; 2021 Feb; 40(2):412-419. PubMed ID: 32600858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
